Physician profile
Narinder S Batra
NPI 1750307658
$3,891.85
in general payments reported to CMS, 2019-2025
18 companies · $918 in 2025
The $918 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $438 · 2020: $69.12 · 2021: $265 · 2022: $478 · 2023: $589 · 2024: $1,136 · 2025: $918.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,631 · Education: $11.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,630.84 |
| Education | $11.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $812.46 | 2023-2025 | Jardiance |
| Boston Scientific Corporation | $808.18 | 2019-2025 | Avvigo Guidance System, Bodyguardian, Lux-Dx Insertable Cardiac Monitor |
| Novartis Pharmaceuticals Corporation | $636.95 | 2019-2025 | |
| Pfizer INC. | $372.13 | 2019-2025 | |
| Shockwave Medical, INC | $316.73 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $224.90 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $168.00 | 2023-2024 | Xarelto |
| Lexicon Pharmaceuticals, INC. | $148.91 | 2023-2024 | Inpefa |
| Bayer Healthcare Pharmaceuticals INC. | $131.71 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $56.40 | 2024 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $42.03 | 2022-2025 | Eliquis |
| Abiomed | $33.06 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $31.71 | 2024 | Arcalyst |
| Amgen INC. | $27.42 | 2023 | Repatha |
| Actelion Pharmaceuticals US, INC. | $24.27 | 2025 | Uptravi, Opsumit |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $23.30 | 2021 | |
| Scpharmaceuticals INC. | $16.96 | 2024 | |
| Ge Healthcare | $16.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Narinder Batra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.